This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: Dainippon Sumitomo Pharma Co., Ltd., Fuji Chemical Industry Co., Ltd.. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012-2016
Title: Keiichi Fujiwara: Innovating Oral Disintegration Technology in Pharmaceuticals
Introduction
Keiichi Fujiwara, an inventive mind from Ibaraki, Japan, has significantly contributed to the field of pharmaceuticals with his groundbreaking innovations. Holding four patents, he has made remarkable strides in developing orally rapidly disintegrating tablets that promise better patient experiences and enhanced effectiveness.
Latest Patents
Among his latest contributions to the pharmaceutical industry are his patents for a disintegrating particle composition and an orally rapidly disintegrating tablet. These inventions address the need for tablets that not only have a pleasing texture and taste but also maintain structural integrity during production, transportation, and post-opening under humid conditions. The disintegrating particle composition involves a mix of mannitol, xylitol, an inorganic excipient, a disintegrating agent, and carmellose, which are carefully processed with water and dried. The resulting rapidly disintegrating tablet combines this composition with an active substance and a disintegrating agent, ensuring that it possesses the desired hardness and excellent disintegration properties.
Career Highlights
Throughout his career, Keiichi Fujiwara has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Fuji Chemical Industry Co., Ltd. and Dainippon Sumitomo Pharma Co., Ltd. His experiences with these esteemed organizations have helped him refine his innovative approaches and develop pharmaceutical solutions that cater to the demands of modern medicine.
Collaborations
In addition to his work at these companies, Fujiwara collaborated with talented coworkers such as Tadashi Fukami and Haruka Koizumi. Their combined expertise and insights have likely played a pivotal role in the successful development of his patents, illustrating the power of teamwork in driving innovation forward.
Conclusion
Keiichi Fujiwara continues to be a vital force in the pharmaceutical industry, combining science and creativity to improve patient care with his inventions. His dedication to developing better disintegrating tablets highlights his commitment to addressing real-world challenges in medication administration, making him a notable inventor in the realm of pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile